Lixte partners with Moffitt for phase Ib/II study of LB-100 in low and intermediate-1 risk MDS Aug. 22, 2018
GNE-616: a promising non-opioid drug candidate for the treatment of Nav1.7-mediated pain Aug. 22, 2018
RSS